Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Betrixaban versus enoxaparin for venous thromboembolism prophylaxis in critically ill patients: findings from the APEX trial Chi, G., Gibson, C. M., Hernandez, A. F., Hull, R. D., Cohen, A. T., Harrington, R. A., Alkhalfan, F., Kalayci, A., Kerneis, M., Nafee, T., Goldhaber, S. Z., APEX Investigators OXFORD UNIV PRESS. 2018: 868
View details for Web of Science ID 000459824002741